hUC-MSC-Exosomes for T2DM - Safety & Efficacy

Clinical trial NCT07693036 · RECRUITING

Trial details

NCT number: NCT07693036
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2026-06-05
Primary completion: 2028-06-04
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.